We are live on
!
Find out more
DRD
Dennis R. Delaney Portfolio holdings
AUM
$282M
1-Year Est. Return
16.32%
This Fund
S&P 500
This Quarter
Est. Return
-0.38%
1 Year Est. Return
+16.32%
3 Year Est. Return
+57.02%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
-$3.72M
(-1.9%)
Cap. Flow
+$904K
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
46.91%
Holding
47
New
2
Increased
22
Reduced
16
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09M |
| 2 |
McCormick & Company Non-Voting
MKC
|
+$853K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$605K |
| 4 |
Carrier Global
CARR
|
+$461K |
| 5 |
NextEra Energy
NEE
|
+$259K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.35M |
| 2 |
PepsiCo
PEP
|
+$941K |
| 3 |
Novartis
NVS
|
+$654K |
| 4 |
NVIDIA
NVDA
|
+$307K |
| 5 |
Ball Corp
BALL
|
+$245K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.71% |
| 2 | Healthcare | 20.62% |
| 3 | Industrials | 12.58% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Consumer Staples | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$468B
| $2.73M | 1.44% |
15,362
| – | – |
|
|
27
Vertex Pharmaceuticals
VRTX
$123B
| $2.61M | 1.37% |
6,470
+1,305
| +25% | +$605K |
|
|
28
McCormick & Company Non-Voting
MKC
$13.8B
| $1.98M | 1.04% |
25,980
+10,860
| +72% | +$853K |
|
|
29
Ball Corp
BALL
$17.8B
| $1.75M | 0.92% |
31,770
-3,992
| -11% | -$245K |
|
30
Becton Dickinson
BDX
$45.3B
| $1.72M | 0.9% |
7,581
-895
| -11% | -$207K |
|
|
31
PepsiCo
PEP
$194B
| $1.32M | 0.69% |
8,655
-5,744
| -40% | -$941K |
|
|
NVO
32
Novo Nordisk
NVO
$225B
| $1.16M | 0.61% |
13,540
-1,015
| -7% | -$110K |
|
|
33
Salesforce
CRM
$150B
| $1.15M | 0.6% |
+3,428
| New | +$1.09M |
|
34
Norfolk Southern
NSC
$77.1B
| $943K | 0.5% |
4,016
| – | – |
|
35
General Mills
GIS
$20.1B
| $510K | 0.27% |
8,000
| – | – |
|
36
ConocoPhillips
COP
$138B
| $422K | 0.22% |
4,254
-208
| -5% | -$22.1K |
|
37
Union Pacific
UNP
$177B
| $395K | 0.21% |
1,732
| – | – |
|
38
Berkshire Hathaway Class B
BRK.B
$1.1T
| $372K | 0.2% |
820
-20
| -2% | -$9.23K |
|
39
Honeywell
HON
$78.4B
| $361K | 0.19% |
1,698
+520
| +44% | +$108K |
|
40
CVS Health
CVS
$139B
| $276K | 0.15% |
6,150
-2,797
| -31% | -$157K |
|
|
41
NextEra Energy
NEE
$188B
| $239K | 0.13% |
+3,340
| New | +$259K |
|
|
42
Medtronic
MDT
$111B
| $234K | 0.12% |
2,925
-15,580
| -84% | -$1.35M |
|
43
Church & Dwight Co
CHD
$23.8B
| $204K | 0.11% |
1,950
| – | – |
|
44
BigBear.ai
BBAI
$1.35B
| $107K | 0.06% |
24,000
| – | – |
|
|
45
Novartis
NVS
$303B
| – | – |
-5,690
| Closed | -$654K |
|
Similar funds
WE
TC
UFAC
DIP
3CP
MFG
BO
BA
Dennis R. Delaney's Q4 2024 Portfolio in Review
As of Q4 2024, Dennis R. Delaney held 47 positions worth $190M, down 1.9% from $194M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Dennis R. Delaney's Q4 2024 filing shows 2 new, 22 increased, 16 reduced and 1 closed positions. Its largest new stake was Salesforce: 3,428 shares worth $1.15M. The largest sale was Medtronic, an estimated $1.35M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Dennis R. Delaney's largest Q4 2024 buy was Salesforce: 3,428 shares worth $1.15M.
- Dennis R. Delaney added most to McCormick & Company Non-Voting in Q4 2024, an estimated $853K increase.
- Dennis R. Delaney's biggest Q4 2024 reduction was Medtronic, cutting an estimated $1.35M.
- Dennis R. Delaney fully exited Novartis in Q4 2024, selling an estimated $654K.
- Dennis R. Delaney's ten largest holdings make up 47% of its $190M portfolio in Q4 2024.
- Dennis R. Delaney opened 2 new positions and closed 1 in Q4 2024.
- Dennis R. Delaney's portfolio value fell 1.9% quarter-over-quarter to $190M.
Based on Dennis R. Delaney's 13F filing for Q4 2024, filed 13 Feb 2025.